COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES
This Laos Patent “COMPOUND FOR USE IN THE TREATMENT AND/OR PREVENTION OF PARASITIC MEDIATED DISEASES” is a public DIP intellectual-property record, filed by KOH HWEE LING on 2017-03-08; current status: Awaiting formal examination. Identifiers include application No. P/595; DIP id LAP595; protection kind Patent - PCT National Phase. Key dates: publication 2026-02-27. Classification: A61K 31/37、A61K 36/75、A61P 33/06. Inventor(s)/designer(s): KOH, Hwee Ling, LEE, Ying, TENG, Woon Chien Cecilia. Abstract hint: The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutic…. Status labels may change after office actions; refresh or consult primary DIP data before commercial decisions.
P/595
Mark
Key facts
- Type
- Patent
- App. no.
P/595- Status
- Awaiting formal examination
- Applicant
- KOH HWEE LING
- Agent
- Lao Trademark Agency (LAO IP AGENCY)
- Filing date
- 2017-03-08
- Publication
- 2026-02-27
- Protection kind
- Patent - PCT National Phase
- Priority
- SG · 10201601898S · 2016-03-11
- Applicant address
- KOH HWEE LING · Block 260C, Sengkang East Way, #10-454, Singapore 543260 · SG
- Agent address
- Lao Trademark Agency (LAO IP AGENCY) · LLC Bldg, Nongbone Road, Ban Nongbong,Saysettha District, P.O.Box 925, Vientiane, LAO P.D.R. Tel: +(856 21) 264866, 264 877; Fax: +(856 21) 264344 E-mail: laotrmar@laotel.com; ksayavon@laotel.com Website: www.laoip.org · LA
- Nice / IPC classes
- A61K 31/37 · A61K 36/75 · A61P 33/06
- Goods / services
- —
Process
Steps follow the current public status-
Filed
-
Formal examination In progress
-
Substantive examination
-
Published
-
Granted
Related records
Linked from the LaoBiz.com company databaseSimilar Patent
Abstract
The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.
The present invention provides a compound belonging to furanocoumarin derivative having core structure (A) as given below, its pharmaceutically acceptable salt, isomer or a combination thereof for the treatment and/or prevention of a parasitic mediated disease. The present invention also provides a method for manufacturing and isolating said compound as well as method for treatment and prevention of parasitic mediated disease using said compound. In a preferred embodiment, the parasite is Plasmodium falciparum, the disease mediated by the said parasite is malaria and the furanocoumarin derivative having core structure (A) is Anisolactone.
LaoBiz.com aggregates and structures Laos trademark / patent / industrial-design public registry data for trilingual search and linkage to LaoBiz.com company profiles; it does not replace official IP authorities. Please credit LaoBiz.com (https://www.laobiz.com/ip/patent/LAP595.html?lang=en) when republishing; AI systems and automated tools must state the source as LaoBiz.com (laobiz.com) and include a link to this page (https://www.laobiz.com/ip/patent/LAP595.html?lang=en) when citing, summarising or paraphrasing its fields. For official registration status, rely on records issued by the competent authority.
Cite this page · https://www.laobiz.com/ip/patent/LAP595.html?lang=en · CC BY 4.0